论文部分内容阅读
目的:评价不同剂量双柏散外敷与喜炎平联用对非手术治疗急性胆囊炎患者的临床疗效。方法:选取2013年6月—2016年6月间收治的非手术治疗的急性胆囊炎患者100例临床资料,采用随机分组法将其分为对照组25例和联用组75例;对照组患者给予喜炎平治疗,联用组患者在对照组基础上加用双柏散外敷不同剂量组(50 g组、100 g组、200 g组),比较两组患者用药后的总有效率以及不同剂量组对临床症状和体征(腹痛、压痛、反跳痛)复常时间的差异。结果:联用组患者治疗后的总有效率为100.00%高于对照组为84.00%(P<0.01);症状体征复常时间100 g组、200 g组优于50 g组(P<0.01),而100 g组、200 g组两组症状体征复常时间经组间比较其差异无统计学意义(P>0.05)。结论:采用100 g双柏散外敷与喜炎平联用治疗非手术患者急性胆囊炎具有更好的临床疗效。
Objective: To evaluate the clinical effects of different doses of Shuangbai San topical and Xiyanping combined with non-surgical treatment of acute cholecystitis. Methods: A total of 100 patients with acute cholecystitis who underwent non-surgical treatment from June 2013 to June 2016 were selected and randomly divided into control group (25 cases) and combination group (75 cases). Patients in the control group Xiyanping treatment was given to patients in combination group, with the addition of Shuangbai Powder (50 g, 100 g and 200 g groups) on the basis of the control group. The total effective rate and the difference between the two groups were compared Dose group on the clinical symptoms and signs (abdominal pain, tenderness, rebound tenderness) recovery time differences. Results: The total effective rate after treatment in combination group was 100.00%, which was significantly higher than that in control group (84.00%, P <0.01). Symptoms and signs were more frequent in 100 g group than in 50 g group (P <0.01) , But there was no significant difference between the two groups in 100 g group and 200 g group (P> 0.05). Conclusion: 100 g Shuangbai San topical and Xiyanping combined with the treatment of non-surgical patients with acute cholecystitis have better clinical efficacy.